Article Versions Notes

Xanthopoulos A, Samt A-K, Guder C, Taylor N, Roberts E, Herf H, Messner V, Trill A, Holzmann KLK, Kiechle M, et al. Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers. Biomedicines. 2023; 11(8):2276. https://doi.org/10.3390/biomedicines11082276

Xanthopoulos, Alexia, Ann-Kathrin Samt, Christiane Guder, Nicholas Taylor, Erika Roberts, Hannah Herf, Verena Messner, Anskar Trill, Katharina Larissa Kreszentia Holzmann, Marion Kiechle, and et al. 2023. "Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers" Biomedicines 11, no. 8: 2276. https://doi.org/10.3390/biomedicines11082276

Xanthopoulos, A., Samt, A. -K., Guder, C., Taylor, N., Roberts, E., Herf, H., Messner, V., Trill, A., Holzmann, K. L. K., Kiechle, M., Seifert-Klauss, V., Zschaeck, S., Schatka, I., Tauber, R., Schmidt, R., Enste, K., Pockley, A. G., Lobinger, D., & Multhoff, G. (2023). Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers. Biomedicines, 11(8), 2276. https://doi.org/10.3390/biomedicines11082276